SCHEMBL5665484

SCHEMBL5665484

O=C(OC(Cl)C(OCc1ccccc1)OCc1ccccc1)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.53
TDP1 Q9NUW8 3/20 0.53
SLC6A2 P23975 1/20 0.53
SLC6A3 Q01959 1/20 0.53
TP53 P04637 1/20 0.50
TSHR P16473 1/20 0.50
CYP2D6 P10635 2/20 0.47
SLC1A3 P43003 2/20 0.46
SLC1A2 P43004 2/20 0.46
SLC1A1 P43005 2/20 0.46
CYP1A2 P05177 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
MEN1 O00255 1/20 0.46
LMNA P02545 4/20 0.45
ALDH1A1 P00352 4/20 0.42
ESR1 P03372 2/20 0.42
ESR2 Q92731 2/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5665462 0.81 KMT2A (0.53) KMT2ATDP1SLC6A2SLC6A3TP53
SCHEMBL26036566 0.79 TP53 (0.71) KMT2ATDP1SLC6A2SLC6A3TP53
SCHEMBL21451175 0.79 TP53 (0.71) KMT2ATDP1SLC6A2SLC6A3TP53
SCHEMBL27777630 0.78 KMT2A (0.56) KMT2ATDP1SLC6A2SLC6A3TP53
SCHEMBL5665262 0.77 TSHR (0.52) KMT2ATDP1SLC6A3TP53TSHR
SCHEMBL5663593 0.77 KMT2A (0.47) KMT2ATDP1SLC6A2SLC6A3TP53
SCHEMBL9446034 0.76 TSHR (0.59) KMT2ATDP1SLC6A2SLC6A3TP53
SCHEMBL2861614 0.75 KMT2A (0.62) KMT2ATDP1SLC6A2SLC6A3CYP2D6
SCHEMBL8677044 0.75 NR4A2 (0.47) KMT2ATDP1SLC6A2SLC6A3MEN1
SCHEMBL19726692 0.74 SLC1A1 (0.56) KMT2ATDP1SLC6A2SLC6A3TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1461041-A4 PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANTIVIRAL NUCLEOSIDES PHARMASSET LTD (BB) 2006-03-29 EP claimed
EP-1461041-A2 PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANTIVIRAL NUCLEOSIDES Pharmasset Ltd. (BB) 2004-09-29 EP claimed
WO-2003051298-A2 PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANTIVIRAL NUCLEOSIDES PHARMASSET LTD. (BB) 2003-06-26 WO claimed